CUBIST PHARMACEUTICALS INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: CUBIST PHARMACEUTICALS INC, 10-Q, EX-10.3, 2000-08-14
Next: G&L REALTY CORP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CIK> 0000912183
<NAME> CUBIST PHARMACEUTICALS, INC.

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      84,038,089
<SECURITIES>                                70,701,717
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            89,433,700
<PP&E>                                      10,095,257
<DEPRECIATION>                             (5,663,906)
<TOTAL-ASSETS>                             161,373,188
<CURRENT-LIABILITIES>                        6,175,099
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        27,112
<OTHER-SE>                                 153,680,449
<TOTAL-LIABILITY-AND-EQUITY>               161,373,188
<SALES>                                              0
<TOTAL-REVENUES>                               608,954
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            10,402,071
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,370,217
<INCOME-PRETAX>                            (7,422,900)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (7,422,900)
<EPS-BASIC>                                      (.28)
<EPS-DILUTED>                                    (.28)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission